AAAAAA

   
Results: 1-22 |
Results: 22

Authors: ALLAIN H BENTUEFERRER D ZEKRI O SCHUCK S LEBRETON S REYMANN JM
Citation: H. Allain et al., EXPERIMENTAL AND CLINICAL METHODS IN THE DEVELOPMENT OF ANTI-ALZHEIMER DRUGS, Fundamental and clinical pharmacology, 12(1), 1998, pp. 13-29

Authors: ZOUHAL H RANNOU F GRATASDELAMARCHE A MONNIER M BENTUEFERRER D DELAMARCHE P
Citation: H. Zouhal et al., ADRENAL-MEDULLA RESPONSIVENESS TO THE SYMPATHETIC NERVOUS ACTIVITY INSPRINTERS AND UNTRAINED SUBJECTS DURING A SUPRAMAXIMAL EXERCISE, International journal of sports medicine, 19(3), 1998, pp. 172-176

Authors: ALLAIN H BENTUEFERRER D
Citation: H. Allain et D. Bentueferrer, CLINICAL EFFICACY OF ALMITRINE-RAUBASINE - AN OVERVIEW, European neurology, 39, 1998, pp. 39-44

Authors: BENTUEFERRER D REYMANN JM ROUSSELLE JC MASSOT O BOURIN M ALLAIN H FILLION G
Citation: D. Bentueferrer et al., 5-HT-MODULINE, A 5-HT1B 1D RECEPTOR ENDOGENOUS MODULATOR, INTERACTS WITH DOPAMINE RELEASE MEASURED IN-VIVO BY MICRODIALYSIS/, European journal of pharmacology, 358(2), 1998, pp. 129-137

Authors: ONEILL MJ HICKS CA WARD MA CARDWELL GP REYMANN JM ALLAIN H BENTUEFERRER D
Citation: Mj. Oneill et al., DOPAMINE D-2 RECEPTOR AGONISTS PROTECT AGAINST ISCHEMIA-INDUCED HIPPOCAMPAL NEURODEGENERATION IN GLOBAL CEREBRAL-ISCHEMIA, European journal of pharmacology, 352(1), 1998, pp. 37-46

Authors: ALLAIN H BENTUEFERRER D
Citation: H. Allain et D. Bentueferrer, INTERROGATIONS AND SOLUTIONS CONCERNING PARKINSONS-DISEASE, La Presse medicale, 26(19), 1997, pp. 909-915

Authors: ALLAIN H BENTUEFERRER D GANDON JM LEDOZE F BELLIARD S
Citation: H. Allain et al., DRUGS USED IN ALZHEIMERS-DISEASE AND NEUROPLASTICITY, Clinical therapeutics, 19(1), 1997, pp. 4-15

Authors: THAMINY S REYMANN JM HERESBACH N ALLAIN H LECHAT P BENTUEFERRER D
Citation: S. Thaminy et al., IS CHLORMETHIAZOLE NEUROPROTECTIVE IN EXPERIMENTAL GLOBAL CEREBRAL-ISCHEMIA - A MICRODIALYSIS AND BEHAVIORAL-STUDY, Pharmacology, biochemistry and behavior, 56(4), 1997, pp. 737-745

Authors: ALLAIN H ZEKRI O FENELON G SCHUCK S BENTUEFERRER D
Citation: H. Allain et al., NEUROTRANSMISSION AND HUNTINGTONS-DISEASE, La Semaine des hopitaux de Paris, 73(15-16), 1997, pp. 509-514

Authors: ALLAIN H BENTUEFERRER D REYMANN JM ROUSSELLE JC MASSOT O BOURIN M FILLION G
Citation: H. Allain et al., DOES 5HT-MODULINE INTERACT WITH THE 5HT(1B) AGONIST CP 93,129-INDUCEDRELEASE OF STRIATAL DOPAMINE IN RATS, British Journal of Pharmacology, 122, 1997, pp. 211-211

Authors: CALDWELL MA REYMANN JM ALLAIN H LEONARD BE BENTUEFERRER D
Citation: Ma. Caldwell et al., LISURIDE PREVENTS LEARNING AND MEMORY IMPAIRMENT AND ATTENUATES THE INCREASE IN EXTRACELLULAR DOPAMINE-INDUCED BY TRANSIENT GLOBAL CEREBRAL-ISCHEMIA IN RATS, Brain research, 771(2), 1997, pp. 305-318

Authors: BENTUEFERRER D MENARD G ALLAIN H
Citation: D. Bentueferrer et al., MONOAMINE-OXIDASE-B INHIBITORS - CURRENT STATUS AND FUTURE POTENTIAL, CNS DRUGS, 6(3), 1996, pp. 217-236

Authors: PAPE D VERNILLET L BELLISSANT E BENTUEFERRER D ALLAIN H
Citation: D. Pape et al., NONINTERCHANGEABILITY OF SPECIFIC RADIOIMMUNOASSAY AND MONOCLONAL-ANTIBODY FLUORESCENT POLARIZATION IMMUNOASSAY IN CYCLOSPORINE MEASUREMENTS, Fundamental and clinical pharmacology, 10(5), 1996, pp. 484-489

Authors: CALDWELL MA REYMANN JM BENTUEFERRER D ALLAIN H LEONARD BE
Citation: Ma. Caldwell et al., THE DOPAMINE AGONISTS LISURIDE AND PIRIBEDIL PROTECT AGAINST BEHAVIORAL AND HISTOLOGICAL-CHANGES FOLLOWING 4-VESSEL OCCLUSION IN THE RAT, Neuropsychobiology, 34(3), 1996, pp. 117-124

Authors: THAMINY S BELLISSANT E MAGINN M DECOMBE R BENTUEFERRER D ALLAIN H BENTUEFERRER D
Citation: S. Thaminy et al., EFFECT OF BRAIN MICRODIALYSIS ON AMINERGIC TRANSMITTER LEVELS IN REPEATED CEREBRAL GLOBAL TRANSIENT ISCHEMIA IN RAT, Journal of neuroscience methods, 70(2), 1996, pp. 185-193

Authors: ONEILL M ALLAIN H BENTUEFERRER D BELLISSANT E DECERTAINES J LEONARD BE
Citation: M. Oneill et al., PHARMACOLOGICAL STRATEGIES IN THE TREATMENT OF CEREBRAL-ISCHEMIA, European neurology, 35, 1995, pp. 28-36

Authors: DELUMEAU JC BENTUEFERRER D GANDON JM AMREIN R BELLIARD S ALLAIN H
Citation: Jc. Delumeau et al., MONOAMINE-OXIDASE INHIBITORS, COGNITIVE FUNCTIONS AND NEURODEGENERATIVE DISEASES, Journal of neural transmission. Supplementum, (41), 1994, pp. 259-266

Authors: SAIAG B MILON D BENTUEFERRER D ALLAIN H RAULT B VANDENDRIESSCHE J
Citation: B. Saiag et al., INHIBITOR EFFECTS OF DILTIAZEM, NICARDIPINE, NIFEDIPINE AND VERAPAMILON THE NOREPINEPHRINE-INDUCED CONTRACTIONS OF THE CANINE SAPHENOUS-VEIN IN CALCIUM-FREE MEDIUM, Research communications in chemical pathology and pharmacology, 83(3), 1994, pp. 255-269

Authors: BENTUEFERRER D BELLISSANT E DECOMBE R ALLAIN H
Citation: D. Bentueferrer et al., TEMPORAL PROFILE OF AMINERGIC NEUROTRANSMITTER RELEASE IN STRIATAL DIALYSATES IN RATS WITH POSTISCHEMIC SEIZURES, Experimental Brain Research, 97(3), 1994, pp. 437-443

Authors: ALLAIN H BELLIARD S DECERTAINES J BENTUEFERRER D BUREAU M LACROIX P
Citation: H. Allain et al., POTENTIAL BIOLOGICAL TARGETS FOR ANTI-ALZHEIMER DRUGS, Dementia, 4(6), 1993, pp. 347-352

Authors: DECOMBE R BENTUEFERRER D ALLAIN H VANDENDRIESSCHE J
Citation: R. Decombe et al., ALTERATION OF AMINERGIC NEUROTRANSMITTER RELEASE AFTER 2 CONSECUTIVE TRANSIENT GLOBAL ISCHEMIAS - AN INVIVO MICRODIALYSIS STUDY IN RAT, Neurological research, 15(3), 1993, pp. 192-197

Authors: ALLAIN H BENTUEFERRER D SAIAG B BELLIARD S THAMINY S
Citation: H. Allain et al., CALCIUM-ANTAGONISTS AND THE CENTRAL-NERVO US-SYSTEM, Therapie, 48, 1993, pp. 697-705
Risultati: 1-22 |